Lacrimal Drainage System and Nasal Cavity Melanoma After Complete Treatment of Conjunctival Melanoma

Overview

Journal Case Rep Ophthalmol Med

Publisher Wiley

Specialty Ophthalmology

Date 2024 Feb 16

PMID 38362357

Authors

Amirreza Veisi

Zahra Dastborhan

Mohsen Dastmardi

Mozhgan Rezaie Kanavi

Saeid Rezaei

Affiliations

Soon will be listed here.

Abstract

Malignant melanoma of the conjunctiva is a rare tumor of the ocular surface with potential fatal consequences and a high likelihood of recurrence. Although routes for extending the tumor, including local, hematogenous, and lymphatogenous, are pretty straightforward, the indirect extension through free-floating tumoral cells to the nasolacrimal duct is not described thoroughly. We report a case of malignant melanoma of the conjunctiva which presented with local recurrence in the intranasal cavity and lacrimal sac two years after the primary surgery (without involvement of the ocular surface and punctum on the second occasion). However, there was no evidence of distant metastasis on either occasion. This case demonstrates the possible noncontiguous spreading route of melanoma tumoral cells and highlights the need for attention to the surgical technique, and careful follow-up to detect further disease activity.

References

Kenawy N, Lake S, Coupland S, Damato B . Conjunctival melanoma and melanocytic intra-epithelial neoplasia. Eye (Lond). 2012; 27(2):142-52. PMC: 3574254. DOI: 10.1038/eye.2012.254. View

Paridaens A, McCartney A, Lavelle R, Hungerford J . Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration. Br J Ophthalmol. 1992; 76(6):369-71. PMC: 504289. DOI: 10.1136/bjo.76.6.369. View

Yu-Wai-Man C, Khaw P . Developing novel anti-fibrotic therapeutics to modulate post-surgical wound healing in glaucoma: big potential for small molecules. Expert Rev Ophthalmol. 2015; 10(1):65-76. PMC: 4364560. DOI: 10.1586/17469899.2015.983475. View

Shields C, Yaghy A, Dalvin L, Vaidya S, Pacheco R, Perez A . Conjunctival Melanoma: Features and Outcomes Based on the Fitzpatrick Skin Type in 540 Patients at a Single Ocular Oncology Center. Ophthalmic Plast Reconstr Surg. 2020; 36(5):490-496. DOI: 10.1097/IOP.0000000000001624. View

Brownstein S . Malignant melanoma of the conjunctiva. Cancer Control. 2004; 11(5):310-6. DOI: 10.1177/107327480401100505. View

Pacheco R, Yaghy A, Dalvin L, Vaidya S, Perez A, Lally S . Conjunctival melanoma: outcomes based on tumour origin in 629 patients at a single ocular oncology centre. Eye (Lond). 2021; 36(3):603-611. PMC: 8873502. DOI: 10.1038/s41433-021-01508-y. View

Vasalaki M, Fabian I, Reddy M, Cohen V, Sagoo M . Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma. Br Med Bull. 2017; 121(1):107-119. DOI: 10.1093/bmb/ldw053. View

Shields C, Markowitz J, Belinsky I, Schwartzstein H, George N, Lally S . Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology. 2010; 118(2):389-95.e1-2. DOI: 10.1016/j.ophtha.2010.06.021. View

Peck T, Schoen M, Padilla M, Rabinowitz M, Curry J, Milman T . Lacrimal drainage apparatus melanoma remotely following treatment and resolution of conjunctival melanoma. Orbit. 2020; 40(5):423-430. DOI: 10.1080/01676830.2020.1808020. View

10.

Kao A, Afshar A, Bloomer M, Damato B . Management of Primary Acquired Melanosis, Nevus, and Conjunctival Melanoma. Cancer Control. 2016; 23(2):117-25. DOI: 10.1177/107327481602300205. View

11.

Vora G, Demirci H, Marr B, Mruthyunjaya P . Advances in the management of conjunctival melanoma. Surv Ophthalmol. 2016; 62(1):26-42. PMC: 5353981. DOI: 10.1016/j.survophthal.2016.06.001. View

12.

Shildkrot Y, Wilson M . Conjunctival melanoma: pitfalls and dilemmas in management. Curr Opin Ophthalmol. 2010; 21(5):380-6. DOI: 10.1097/ICU.0b013e32833b7aab. View

13.

Shields C, Shields J, Gunduz K, Cater J, Mercado G, Gross N . Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000; 118(11):1497-507. DOI: 10.1001/archopht.118.11.1497. View

14.

Kanavi M, Hosseini S, Aliakbar-Navahi R, Aghaei H . Impression Cytology in a Series of Clinically Diagnosed Ocular Surface Melanocytic Lesions. J Ophthalmic Vis Res. 2017; 12(1):17-22. PMC: 5340058. DOI: 10.4103/jovr.jovr_72_16. View

15.

McNab A, McKelvie P . Malignant melanoma of the lacrimal sac complicating primary acquired melanosis of the conjunctiva. Ophthalmic Surg Lasers. 1997; 28(6):501-4. View

16.

Hu D, Yu G, McCormick S, Finger P . Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas. Am J Ophthalmol. 2008; 145(3):418-423. DOI: 10.1016/j.ajo.2007.10.022. View

17.

Rao R, Honavar S, De Padua M, Mulay K, Reddy V . Melanorrhea: Noncontiguous spread of palpebral conjunctival melanoma to the nasolacrimal duct. Indian J Ophthalmol. 2018; 66(2):302-303. PMC: 5819123. DOI: 10.4103/ijo.IJO_886_17. View

18.

Wang H, Elsheikh M, Gilmour K, Cohen V, Sagoo M, Damato B . Impact of COVID-19 pandemic on eye cancer care in United Kingdom. Br J Cancer. 2021; 124(8):1357-1360. PMC: 8039025. DOI: 10.1038/s41416-021-01274-4. View

19.

Shields J, Shields C, De Potter P . Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol. 1997; 115(6):808-15. DOI: 10.1001/archopht.1997.01100150810025. View

20.

Missotten G, Gambrelle J, de Wolff-Rouendaal D, de Keizer R . Epistaxis or epiphora as a sign for extension of a conjunctival melanoma. A series of six patients with nasolacrimal recurrence. Br J Ophthalmol. 2010; 94(10):1328-31. DOI: 10.1136/bjo.2009.168823. View